Company intelligence / Profile preview

Hx Bio Ventures

Düsseldorf, North Rhine-Westphalia, Germany

Ownership: Private
Development stage: Other

Overview

Hx Bio Ventures is an early-stage life science venture investor; it does not itself run clinical trials, but has funded companies such as Abalos Therapeutics to advance arenavirus-based immuno-virotherapy into Phase 1/2 oncology trials.

Modalities: Biologic
Industry: Investors

Partnerships

Abalos Therapeutics (portfolio investment in arenavirus-based immuno-virotherapy for cancer)

Beyond the preview

Go deeper on Hx Bio Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hx Bio Ventures.

Explore the full profile